Zoplar Raises $3.4M Series A to Transform Medical Equipment Access for MSME Hospitals.
Zoplar, an innovative platform dedicated to enhancing the medical equipment procurement process for small and medium-sized hospitals in India, has successfully raised $3.4 million in a Series A funding round led by Blume Ventures. The round also saw participation from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX. In total, the company has raised $5.1 million in funding with contributions from Titan Capital, Stride Ventures and Panthera Peak. With the newly raised funding, Zoplar plans to strengthen its operational capabilities by focusing on backward integration in the supply chain and developing a robust service engineering team. This will enable the company to deliver best-in-class after-sales service while leveraging technology to enhance efficiency.
With India's healthcare infrastructure rapidly evolving, Zoplar is positioned at the forefront of this transformation. By crafting a full-stack medical equipment platform, the startup addresses significant pain points MSME hospitals face, including the complexities of identifying price-optimal products, managing multiple vendor relationships, ensuring high-quality after-sales service, and accessing financing solutions.
The journey of Zoplar began when co-founder Amit, drawing from his extensive healthcare background, recognized the struggles of MSME hospitals regarding reliable medical equipment purchases and support. Alongside close friend Umesh, the duo conducted comprehensive research on these challenges and decided to streamline India's medtech buying and after-sales experience. The pair’s previous collaboration at OYO laid a strong foundation for the partnership that drives Zoplar today.
Amit Sah and Umesh Sharma, Co-founder of Zoplar said "We are thrilled to have the trust and support of our investors," said "This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies. It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care.”
Sajith Pai VC at Blume Ventures lead investor stated, “We invested in Zoplar because we believe in their vision and the potential impact they can have on the healthcare landscape in India,” “Their commitment to improving the procurement and after-sales service in medical equipment is commendable and aligns with our focus on supporting ventures that drive meaningful societal change.”
We are excited to support Zoplar in their mission to empower MSME hospitals with the tools they need to thrive,” said Anirudh Garg, Partner at Beenext. “The team’s deep understanding of the healthcare landscape and their innovative approach to addressing critical challenges in medical equipment procurement present a compelling investment opportunity. We believe Zoplar has the potential to significantly enhance the quality of healthcare delivery in India, and we are proud to partner with them on this transformative journey.”
Since its inception, Zoplar has gained significant momentum in the market, partnering with approximately 300 hospitals, including prominent nephrology chains such as DCDC. The company boasts a 40% rate of repeat customers, underscoring the demand for quality medical equipment in the sector.